×
AllNewsImagesMaps Videos Shopping Books
Search tools
Showing results for Arbutus Biopharma
Search instead for Arbutus Biopharm

Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo Finance
Arbutus Biopharma ( NASDAQ:ABUS ) First Quarter 2024 Results Key Financial Results Revenue: US$1.53m (down 77% from 1Q...
1 day ago

Arbutus Biopharma Announces Chief Scientific Officer's Retirement - TipRanks.com

Tipranks
An announcement from Arbutus Biopharma Corporation (ABUS) is now available. Dr. Michael Sofia will retire as Chief Scientific Officer from Arbutus Biopharma...
2 days ago

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

Zacks Investment Research
Here is how Arbutus Biopharma (ABUS) and Entera Bio Ltd. (ENTX) have performed compared to their sector so far this year.
4 days ago

Arbutus: Q1 Earnings Snapshot

Milford Mirror
WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Thursday reported a loss of $17.9 million in its first...
1 day ago

Arbutus Biopharma CSO Dr. Michael Sofia to retire by year-end

Investing.com
WARMINSTER, Pa. - Arbutus Biopharma (NASDAQ:ABUS) Corporation (NASDAQ:ABUS), a company focused on developing treatments for chronic...
1 day ago

Arbutus, Genevant gain an edge in COVID patent scrap with Moderna

Fierce Pharma
With a new order clarifying several terms of the patents at the center of Arbutus Biopharma and Genevant Sciences' infringement suit against...
1 month ago

Arbutus Biopharma Co-Founder Dr. Michael Sofia to Retire After a Storied Career in Antiviral Drug Discovery

MyChesCo
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the upcoming retirement of its co-founder and Chief Scientific...
1 day ago

ABUS (Arbutus Biopharma) 14-Day RSI

GuruFocus
What is Arbutus Biopharma 14-Day RSI? The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements.
4 days ago

Arbutus Biopharma CSO Sets Retirement Date - TipRanks.com

Tipranks
Arbutus Biopharma Corporation announced the retirement of its co-founder and Chief Scientific Officer, Dr. Michael J. Sofia,...
2 days ago

Arbutus Biopharma Makes Headway in Hepatitis B Treatment and Defends Intellectual Property Amidst Q1 2024 ...

MyChesCo
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has unveiled its growth during the first quarter of 2024, particularly in the...
1 day ago